LORIOT, Y., Necchi, A., Singh, P., Pagliaro, L., Pal, S., Castellano, D., & Suárez, C. (2025). COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts.
Citação norma ChicagoLORIOT, YOHANN, Andrea Necchi, Parminder Singh, Lance Pagliaro, Sumanta Pal, Daniel Castellano, e Cristina Suárez. COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results From the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts. 2025.
Citação norma MLALORIOT, YOHANN, et al. COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results From the Locally Advanced or Metastatic Urothelial Carcinoma Cohorts. 2025.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.